Sibylle Junge

1.4k total citations
23 papers, 667 citations indexed

About

Sibylle Junge is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Sibylle Junge has authored 23 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Sibylle Junge's work include Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (5 papers) and Child Nutrition and Feeding Issues (3 papers). Sibylle Junge is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (5 papers) and Child Nutrition and Feeding Issues (3 papers). Sibylle Junge collaborates with scholars based in Germany, Switzerland and Latvia. Sibylle Junge's co-authors include Manfred Ballmann, Alexandra Hebestreit, Helge Hebestreit, Susi Kriemler, Thomas Schenk, Christian Schindler, Christian Schindler, Stefan G. Rüdiger, Susanne Fuchs and Kristina Roth and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Sibylle Junge

23 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sibylle Junge Germany 13 593 125 85 61 59 23 667
James D. Acton United States 13 519 0.9× 43 0.3× 80 0.9× 74 1.2× 73 1.2× 22 622
Larissa German Israel 12 86 0.1× 336 2.7× 91 1.1× 22 0.4× 36 0.6× 17 585
Geraldine Nolan Ireland 11 136 0.2× 131 1.0× 16 0.2× 22 0.4× 27 0.5× 23 410
Juan Luis García‐Rivero Spain 16 486 0.8× 276 2.2× 66 0.8× 79 1.3× 8 0.1× 51 626
René van Gent Netherlands 11 279 0.5× 293 2.3× 15 0.2× 60 1.0× 48 0.8× 18 468
Marcelo Velloso Brazil 13 363 0.6× 79 0.6× 30 0.4× 20 0.3× 14 0.2× 47 506
Ilia Bresesti Italy 11 104 0.2× 32 0.3× 24 0.3× 39 0.6× 7 0.1× 37 314
Arietta Spinou United Kingdom 10 365 0.6× 172 1.4× 20 0.2× 36 0.6× 66 1.1× 33 418
Jodi Hilton Australia 7 360 0.6× 153 1.2× 20 0.2× 154 2.5× 19 0.3× 17 485
A Richard France 5 143 0.2× 215 1.7× 55 0.6× 48 0.8× 23 0.4× 16 455

Countries citing papers authored by Sibylle Junge

Since Specialization
Citations

This map shows the geographic impact of Sibylle Junge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibylle Junge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibylle Junge more than expected).

Fields of papers citing papers by Sibylle Junge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibylle Junge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibylle Junge. The network helps show where Sibylle Junge may publish in the future.

Co-authorship network of co-authors of Sibylle Junge

This figure shows the co-authorship network connecting the top 25 collaborators of Sibylle Junge. A scholar is included among the top collaborators of Sibylle Junge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibylle Junge. Sibylle Junge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeLuca, David S., Martin Wetzke, Christian Dopfer, et al.. (2023). Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity. Frontiers in Pharmacology. 14. 1171544–1171544. 5 indexed citations
2.
Stanke, Frauke, Stephanie Tamm, Silke Hedtfeld, et al.. (2023). Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy. Frontiers in Pharmacology. 14. 1114584–1114584. 9 indexed citations
3.
Janzen, Nils, Jan Fuge, Christian Klemann, et al.. (2022). The First 4 Years – Outcome of Children Identified by Newborn Screening for CF in Germany. Klinische Pädiatrie. 234(5). 284–292. 3 indexed citations
4.
Junge, Sibylle, Felix C. Ringshausen, Annette Sauer‐Heilborn, et al.. (2021). CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the β-adrenergic sweat rate assay. Journal of Cystic Fibrosis. 21(3). 442–447. 9 indexed citations
5.
Goldbeck, Lutz, Dunja Tutus, Jörg M. Fegert, et al.. (2021). Professional quality of life among health care professionals in cystic fibrosis and child and adolescent mental health. Journal of Workplace Behavioral Health. 37(1). 9–30. 1 indexed citations
6.
Schulz, Angela, Christian Dopfer, Gesine Hansen, et al.. (2020). Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test. BMJ Open Respiratory Research. 7(1). e000736–e000736. 17 indexed citations
7.
Junge, Sibylle, Christian Dopfer, Annette Sauer‐Heilborn, et al.. (2019). Assessment of a Mobile App by Adolescents and Young Adults With Cystic Fibrosis: Pilot Evaluation. JMIR mhealth and uhealth. 7(11). e12442–e12442. 19 indexed citations
8.
Hebestreit, Helge, Sibylle Junge, Manfred Ballmann, et al.. (2014). Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulmonary Medicine. 14(1). 26–26. 106 indexed citations
9.
Scheuing, Nicole, Reinhard W. Holl, Julia M. Hermann, et al.. (2014). High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study. PLoS ONE. 9(11). e112578–e112578. 48 indexed citations
10.
Kriemler, Susi, Sibylle Junge, Manfred Ballmann, et al.. (2013). Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial. Journal of Cystic Fibrosis. 12(6). 714–720. 63 indexed citations
11.
Scheuing, Nicole, Reinhard W. Holl, Katharina Fink, et al.. (2013). Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines. PLoS ONE. 8(12). e81545–e81545. 19 indexed citations
12.
Junge, Sibylle, et al.. (2012). 253 Phase angle (PA) from bioelectrical impedance analysis (BIA) in children with cystic fibrosis (CF). Journal of Cystic Fibrosis. 11. S121–S121. 1 indexed citations
13.
Fuchs, Susanne, Sibylle Junge, Helmut Ellemunter, Manfred Ballmann, & Monika Gappa. (2012). Calculation of the capnographic index based on expiratory molar mass–volume-curves — A suitable tool to screen for cystic fibrosis lung disease. Journal of Cystic Fibrosis. 12(3). 277–283. 10 indexed citations
14.
Stanke, Frauke, Stephanie Tamm, B. Siebert, et al.. (2010). Functional analysis of F508del CFTR in native human colon. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(11). 1062–1069. 26 indexed citations
15.
Riethmueller, J., Manfred Ballmann, Andreas Claaß, et al.. (2009). Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients. Infection. 37(5). 424–431. 27 indexed citations
16.
Riethmueller, J., Sibylle Junge, Manfred Ballmann, et al.. (2009). Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis. Infection. 37(5). 418–423. 35 indexed citations
17.
Hebestreit, Helge, Sibylle Junge, Manfred Ballmann, et al.. (2009). Long-term effects of a partially supervised conditioning programme in cystic fibrosis. European Respiratory Journal. 35(3). 578–583. 108 indexed citations
18.
Fuchs, Susanne, et al.. (2008). A novel sidestream ultrasonic flow sensor for multiple breath washout in children. Pediatric Pulmonology. 43(8). 731–738. 40 indexed citations
19.
Hebestreit, Helge, Stefan G. Rüdiger, Thomas Schenk, et al.. (2006). Physical activity is independently related to aerobic capacity in cystic fibrosis. European Respiratory Journal. 28(4). 734–739. 100 indexed citations
20.
Ballmann, Manfred, Sibylle Junge, & H. von der Hardt. (2003). Low-dose methotrexate for advanced pulmonary disease in patients with cystic fibrosis. Respiratory Medicine. 97(5). 498–500. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James D. Acton Breakdown of academic impact, for papers by Larissa German Breakdown of academic impact, for papers by Geraldine Nolan Breakdown of academic impact, for papers by Juan Luis García‐Rivero Breakdown of academic impact, for papers by René van Gent Breakdown of academic impact, for papers by Marcelo Velloso Breakdown of academic impact, for papers by Ilia Bresesti Breakdown of academic impact, for papers by Arietta Spinou Breakdown of academic impact, for papers by Jodi Hilton Breakdown of academic impact, for papers by A Richard
Rankless by CCL
2026